Ditch Partners With The CRIQ, Investissement Québec's World-Renowned Laboratory, For Nonclinical Testing

MONTREAL, QC/January, 2022 – Ditch Labs, Inc.’s partnership with the CRIQ led by Research Director and Partner Christelle Luce, Co-Founder and CTO Olivier Bourbonnais and Pharmacologist Mehdi El Hassani, will serve the objective of characterizing the aerosol generated by the DitchPen™. The company intends to present a toxicology report to the FDA and Health Canada in order to receive a Clinical Trial Authorization (Health Canada) and an Investigational New Drug approval (FDA).

Ditch Labs Receives Funding From The National Research Council's IRAP Program

MONTREAL, QC/December, 2021 – Following the partnership between Ditch Labs, Inc. and the CRIM along with professional recommendations, the company’s application for the non-dilutive funding of the National Research Council’s IRAP program is now approved. These additional funds will finance the fees of the CRIM researchers.

Ditch Partners Up With The Computer Research Institute of Montréal (CRIM) To Develop Its Treatment Algorithms

MONTREAL, QC/December, 2021 – The partnership of Ditch Labs, Inc. with the CRIM to develop its treatment algorithms led by Research Director and Partner Christelle Luce, Co-Founder and CTO Olivier Bourbonnais, Software Director Étienne Bélanger and Researcher Gabrielle Toupin, will strengthen the cybersecurity of its solutions and allow the company to develop algorithms based on the data it collects from the DitchPen™ and from the DitchApp™, among other important aspects.